Soliton, Inc. SOLY

Soliton, Inc. General and Administrative Expenses 2011-2025 | SOLY

General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.

What these expenses include

Salaries of administrative staff (executives, HR, accountants, legal personnel)
Office rent and utilities
Office equipment and IT infrastructure
Professional services (auditors, lawyers, consultants)
Insurance
General administrative travel and representation expenses

What the metric indicates

Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure
Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit
Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry
Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines

Annual General and Administrative Expenses Soliton, Inc.

2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
8.46 M	7.43 M	3.11 M	3 M	3.05 M	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
8.46 M	3 M	5.01 M

General and Administrative Expenses of other stocks in the Medical devices industry

Issuer	General and Administrative Expenses	Price	% 24h	Market Cap	Country
Apyx Medical Corporation APYX	22.2 M	$ 3.86	-3.26 %	$ 134 M	USA
BioSig Technologies BSGM	11.6 M	-	37.08 %	$ 85.7 M	USA
Abiomed ABMD	334 M	-	-	$ 17.2 B	USA
GenMark Diagnostics, Inc. GNMK	25.6 M	-	-	$ 1.77 B	USA
Cutera CUTR	63.3 M	-	-10.19 %	$ 1.99 M	USA
Eargo EAR	54.3 M	-	-	$ 10.2 M	USA
Obalon Therapeutics, Inc. OBLN	8.78 M	-	-5.86 %	$ 30.6 M	USA
Bio-Rad Laboratories BIO	814 M	$ 307.92	-1.93 %	$ 8.69 B	USA
Apollo Endosurgery APEN	20.6 M	-	-	$ 475 M	USA
Acutus Medical AFIB	14.1 M	-	-26.83 %	$ 2.62 M	USA
Bruker Corporation BRKR	894 M	$ 45.13	-2.67 %	$ 6.72 K	USA
Allied Healthcare Products AHPI	7.11 M	-	3.58 %	$ 2.21 M	USA
Conformis CFMS	28.8 M	-	-	$ 16.4 M	USA
Abbott Laboratories ABT	11.7 B	$ 125.1	1.48 %	$ 218 B	USA
Boston Scientific Corporation BSX	5.98 B	$ 92.34	0.64 %	$ 136 B	USA
CryoLife, Inc. CRY	141 M	-	-4.14 %	$ 702 M	USA
EDAP TMS S.A. EDAP	5.9 M	$ 2.56	8.94 %	$ 95.5 M	France
Invacare Corporation IVC	227 M	-	-	$ 24.7 M	USA
Cardiovascular Systems CSII	171 M	-	0.15 %	$ 844 M	USA
IRIDEX Corporation IRIX	8.75 M	$ 0.92	-4.72 %	$ 14.8 M	USA
IRadimed Corporation IRMD	15.9 M	$ 96.35	-1.06 %	$ 1.22 B	USA
OrthoPediatrics Corp. KIDS	103 M	$ 17.7	-3.46 %	$ 408 M	USA
Hancock Jaffe Laboratories, Inc. HJLI	4.88 K	-	-1.98 %	$ 98.3 M	USA
Itamar Medical Ltd. ITMR	8.5 M	-	0.03 %	$ 1.58 B	Israel
Misonix, Inc. MSON	18 M	-	-	$ 462 M	USA
Neovasc NVCN	14.7 M	-	-	$ 111 M	Canada
LivaNova PLC LIVN	526 M	$ 62.79	-1.82 %	$ 3.41 B	Britain
Pulmonx Corporation LUNG	102 M	$ 2.53	0.86 %	$ 99 M	USA
Dynatronics Corporation DYNT	8.46 M	-	14.99 %	$ 929 K	USA
Intersect ENT, Inc. XENT	98.6 M	-	-	$ 955 M	USA
InMode Ltd. INMD	8.41 M	$ 14.56	0.76 %	$ 1.15 B	Israel
Cognyte Software Ltd. CGNT	163 M	$ 9.88	0.05 %	$ 709 M	Israel
Myomo MYO	18.4 M	$ 1.06	-1.85 %	$ 7.47 M	USA
Second Sight Medical Products EYES	806 K	-	-0.97 %	$ 54.4 M	USA
Integra LifeSciences Holdings Corporation IART	717 M	$ 13.41	-4.56 %	$ 1.03 B	USA
NuVasive NUVA	634 M	-	-	$ 2.07 B	USA
Align Technology ALGN	1.76 B	$ 165.15	0.78 %	$ 12.4 B	USA
Accuray Incorporated ARAY	47.9 M	$ 1.07	-3.18 %	$ 110 M	USA
Avinger AVGR	14.1 M	-	-20.74 %	$ 369 K	USA
ClearPoint Neuro CLPT	12 M	$ 12.81	-1.23 %	$ 346 M	USA
Orthofix Medical OFIX	533 M	$ 15.51	-1.27 %	$ 591 M	Curacao
FONAR Corporation FONR	23.5 M	$ 14.86	-0.03 %	$ 97.4 M	USA
AxoGen AXGN	39 M	$ 30.33	1.15 %	$ 1.34 B	USA
Axonics Modulation Technologies AXNX	40.2 M	-	-	$ 3.31 B	USA
GBS GBS	8.88 M	-	-0.57 %	$ 7.12 M	USA
CONMED Corporation CNMD	117 M	$ 40.78	2.33 %	$ 1.26 B	USA
LENSAR LNSR	26.5 M	$ 11.48	-0.17 %	$ 132 M	USA